<p>Table S1 Summary of amino acid sequence homology analysis by NCBI Protein Blast Program with 124 tryptic peptides identified from CA215 by MALDI-TOF MS Amino Acid Sequence of Tryptic Peptides Sequence Homology Searched (%) 1. AAAGGLAMLTSMRPTLCSR Immunoglobulin heavy chain variable region (68%)</p><p>ICAM-3 (36%)</p><p>2. ADQGSETPSCLEVQCWGSR CD55 antigen, decay accelerating factor for complement (Cromer blood group), isoform CRA_j (52%)</p><p>Protocadherin alpha-10 isoform 3 precursor (36%)</p><p>3. AEALRTLTK Nestin (100%)</p><p>Microtubule-based motor (77%)</p><p>4. AFGSAAAFCWLCPCRCWK Adhesion molecule with Ig-like domain 1 (27%)</p><p>5. AGLLCHLDDACISNPCHK Delta and Notch-like epidermal growth factor-related receptor precursor (72%)</p><p>Dynein heavy chain 14, axonemal isoform 1 (83%)</p><p>Cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila), isoform CRA_a (66%)</p><p>6. ALACSGMKIGR ligatin, isoform CRA_c (54%)</p><p>TCR (72%)</p><p>MHC class I antigen (90%)</p><p>7. ANESGLAMTDISSLASQNK Melanoma associated antigen (mutated) 1 (36%) Tubulin gamma-1 chain (57%)</p><p>1 Cathepsin F (63%)</p><p>8. ANPQCMGQNHK Prolow-density lipoprotein receptor-related protein 1 precursor (90%)</p><p>9. APQLLCYAATNLQSGGPSR Anti-tetanus toxoid immunoglobulin light chain variable region (100%)</p><p>10. APTVVLHMTK Ig heavy chain variable region, VH3 family (70%)</p><p>Mucin 5AC protein (70%)</p><p>NF-IL6-beta protein (80%) 11. AQCVVSLAPR Interleukin-1 receptor accessory protein isoform 3 (50%)</p><p>MEGF10 protein, isoform CRA_b (100%)</p><p>Obscurin (80%)</p><p>12. ATVASGISPGWMGLDCGPESNK Circulating B cell antibody heavy chain variable region (59%)</p><p>Immunoglobulin E heavy chain variable region (50%)</p><p>Multiple epidermal growth factor-like domains protein 11 precursor (40%)</p><p>13. ATVMGSKCHR Mucin-16 (70%)</p><p>14. AVMNGLAPGSNGQDKDMDLTK Cellular myosin heavy chain (38%)</p><p>Fc receptor-like A (100%)</p><p>15. AVPSAEPQAGSPMTLSCQTK Leukocyte immunoglobulin-like receptor subfamily A member 2 soluble isoform 2 (85%) 16. CDVLK WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2, isoform CRA_b (100%) 17. CNGLMTIVFEENSKVTVPHMIK Immunoglobulin lambda chain variable region (59%)</p><p>2 18. DGLLYDTLVLINLESCDKK Nuclear receptor ROR-gamma isoform b (47%)</p><p>19. DHPYISEIK Fat-like cadherin FATJ protein (77%)</p><p>20. EAHFVRTSGK neural cell adhesion molecule 1, isoform CRA_h (70%)</p><p>21. EEAGKEEPPPLTPPAR T-box 3 (ulnar mammary syndrome), isoform CRA_d (100%) </p><p>22. EGAAGAFLPACK Multiple epidermal growth factor-like domains protein 8 (66%)</p><p>Immunoglobulin heavy chain variable region (58%)</p><p>23. EGGTQKTSTLPAVLYSCGICK Immunoglobulin heavy chain variable region (28%)</p><p>24. EMTDATNEEETEIKEDTK Ryanodine receptor 2 (cardiac), isoform CRA_c (77%)</p><p>25. GDGTSQGCAVPVESDPRHPR Pro-epidermal growth factor isoform 3 preproprotein (65%)</p><p>Titin (90%)</p><p>26. GDRVTITWR Immunoglobulin kappa chain variable region (100%)</p><p>Immunoglobulin light chain variable region (77%)</p><p>27. GELSPGHFLSGFSAAGASV Ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin), isoform CRA_b (31%)</p><p>28. GLCASAPFSCCLEQDVSRK T cell receptor beta variable 19 (36%)</p><p>Immunoglobulin mu heavy chain (63%)</p><p>29. GLEWVSAVSGSGTTTYYADSVK Immunoglobulin heavy chain variable region (100%)</p><p>Immunoglobulin E heavy chain variable region </p><p>3 (100%)</p><p>Immunoglobulin alpha heavy chain variable region (100%)</p><p>Anti-GM2 glanglioside IgM heavy chain variable region (100%)</p><p>30. GQPTYQICPRIIPTTESSCR NWD1 protein (30%)</p><p>31. GSSGSSGKCETK N.A.</p><p>32. GTEGLCPLLCHADGTPLGAGAR Sialic acid-binding Ig-like lectin 6 isoform 6 precursor (63%)</p><p>CD33L1 [Homo sapiens] >gb|AAK83655.1| sialic acid binding immunoglobulin-like lectin 6 (63%)</p><p>CD33L2 (63%)</p><p>Latent TGF-beta binding protein-4 (31%) 33. HESHRAVEFYQVVCVVFVFYYAK Receptor-type tyrosine-protein phosphatase beta isoform a (34%)</p><p>Protein tyrosine phosphatase, receptor type, B (34%)</p><p>34. HIISHSGNNPYGCEECGK CLL-associated antigen KW-4 splice variant 2 (94%)</p><p>35. IGTMVEDHR Titin (100%)</p><p>Complement component C8 beta chain preproprotein (55%)</p><p>36. KGGHSSPASSDK Mast cell-expressed membrane protein (75%)</p><p>37. KGYIPSYLDK Thyroid hormone receptor beta isoform (100%)</p><p>Immunoglobulin kappa 1 light chain (70%)</p><p>38. KHPSTVQVK T-cell leukemia translocation altered gene, isoform CRA_b (88%)</p><p>4 B-cell receptor CD22 isoform 3 precursor (77%)</p><p>V-set and immunoglobulin domain-containing protein 10-like (88%)</p><p>39. KTDQMVFHLETNSNSESHDK Protein tyrosine phosphatase, non-receptor type 20A (55%)</p><p>Breast cancer-associated antigen SGA-72M (60%)</p><p>40. LEPGNCKADETASK Protein-coupled receptor 112 (100%)</p><p>Cancer antigen 1 (71%)</p><p>41. LGLRCVTCNYCSQLCK Deformed epidermal autoregulatory factor 1 variant (93%)</p><p>42. LNTPTDSTLWVSLCCPR Titin isoform novex-2 (64%)</p><p>CDC42 binding protein kinase alpha (DMPK-like) (52%)</p><p>43. LSPLESRPPCPAGLVR Immunoglobulin kappa light chain variable region (100%)</p><p>Carbohydrate (keratan sulfate Gal-6) sulfotransferase 1, isoform CRA (68%)</p><p>Discoidin domain receptor family, member 1 (56%)</p><p>Receptor tyrosine kinase (56%)</p><p>44. LSTGVFGGGTK Immunoglobulin lambda light chain VLJ region (100%)</p><p>Immunoglobulin light chain variable region (100%)</p><p>Immunoglobulin V lambda/J lambda light chain (90%)</p><p>45. MAYLDQTLAGPSGTR Immunoglobulin kappa chain variable region (53%)</p><p>46. MCSCPISSPGHIKGLGQEETPVR Interleukin 23 receptor (30%)</p><p>5 Kainate receptor subunit KA2a (65%)</p><p>Glutamate receptor subunit (47%)</p><p>47. MIDSVMSCQQLTGLK Dynein heavy chain 2, axonemal (93%)</p><p>Dynein heavy chain domain 3, isoform CRA_c (86%)</p><p>48. MMGSTHIYDMSTVMSR Progestin and adipoQ receptor family member III, isoform CRA_b (50%)</p><p>49. MPIMLRSSNCVLTGK Vascular endothelial growth factor D preproprotein (73%)</p><p>T cell receptor alpha-chain V-region (V-J-C) precursor (73%)</p><p>50. MSLEWLVAWSWSLDGLR CD19 antigen, isoform CRA_c (52%)</p><p>Immunoglobulin heavy chain variable region (76%)</p><p>51. MSLLHKHQESGCSGCPR Relaxin receptor 2 isoform 1 (35%)</p><p>52. MSPSLFLPAMKEGCNAYK Nebulin isoform 2 (94%)</p><p>53. MSSNCTSTTAVAVAPLSASK Ig heavy chain (40%)</p><p>Immunoglobulin heavy chain variable region (50%)</p><p>Mucin-19-like (100%)</p><p>54. MSSPGPSQPPAEDPPWPAR Myopodin protein (84%)</p><p>55. MSTMRLLTLALLFSCSVAR Fibroblast growth factor receptor 4, isoform CRA_a (47%)</p><p>56. MSTRYHQAASDSYLELLK Dynein, axonemal, heavy chain 11 (100%)</p><p>57. MVKSYFCYAEQELMK Insulin-like growth factor 2 mRNA binding protein 1, </p><p>6 isoform CRA_b (46%)</p><p>58. MVMHARSGGNLEVMGLMLGK Receptor-type protein tyrosine phosphatase beta, RPTP beta, PTP zeta [human, brainstem, Peptide, 2307 aa] (45%)</p><p>Receptor-type tyrosine-protein phosphatase U isoform 2 precursor (65%)</p><p>Interleukin-20 receptor subunit beta precursor (70%)</p><p>59. NTDEPMGITLKMLNHCIVAR 55 kDa erythrocyte membrane protein isoform 4 (70%)</p><p>60. PATAPSCPSGSR Epidermal growth factor receptor isoform a variant (66%)</p><p>Mucin 5 (83%)</p><p>61. SAEPRGGVQVTTQQPR Cingulin (56%)</p><p>62. SEMVLYIQSEPVSQDAKPTGHNR Cell adhesion kinase beta (30%)</p><p>63. SESEEALPLDLDKNIHTPVSRPNR Major histocompatibility complex, class I, E (83%)</p><p>64. SGRPEELVSCADCGRSGGSGR Retinoid X receptor, alpha, isoform CRA_a (71%)</p><p>65. SISRPSSLRMSR Breast cancer nuclear receptor-binding auxiliary protein (66%)</p><p>66. SIVHPSYNSNTLNNDIMLIK Cathepsin 6 preprotein (75%) 67. SLSCESLWPIEAR Latrophilin-3 precursor (92%) 68. SMPTNCVWLDGLSSNVSDQYLTR Vascular endothelial growth factor receptor 1 isoform 4 precursor (73%)</p><p>Dynein heavy chain domain 1 isoform 1 (39%)</p><p>Cadherin-7 (56%)</p><p>Neuronal cell adhesion molecule isoform E precursor </p><p>7 (47%)</p><p>Immunoglobulin heavy chain (56%)</p><p>69. SPAQYQVVLSERLQALVNSLCAGQSP Tumor necrosis factor receptor superfamily member EDAR precursor (46%)</p><p>Trabeculin-alpha (100%)</p><p>70. SSGTSYPDVLK Immunoglobulin heavy chain variable region (100%)</p><p>Immunoglobulin gamma 1 heavy chain variable region (72%)</p><p>71. STNLPRNPSMADYEAR Protocadherin-8 isoform 2 precursor (50%)</p><p>72. TAAEADMDAAAGPPVSTRQSK Nuclear receptor co-repressor (100%)</p><p>73. TAKGSTGMEILLSTLENTK Immunoglobulin A heavy chain variable region (94%)</p><p>Immunoglobulin heavy chain variable region VH (78%)</p><p>Immunoglobulin gamma 3 heavy chain variable region (94%)</p><p>74. TAKPASQEHARCSAIGTGESPK Profilaggrin (86%) 75. TATIIIHANASMSHTILLK Cadherin-related family member 4 precursor (36%)</p><p>76. TGDPSPCPTPSHFDGVCDISCCEVK Mucin-2 precursor (96%) 77. TRTSFTAEQLYR Coronin, actin binding protein, 1B, isoform CRA_c (58%)</p><p>78. TSGATQTTVGDALFTR MHC class I antigen (56%)</p><p>Interleukin-9 (50%)</p><p>79. TSTGAVRMQPK Immunoglobulin gamma 2 heavy chain variable region (81%)</p><p>80. TVAMAGVAAMTAVTR HLA-B associated transcript 3 (100%)</p><p>8 81. TVCVLSERR Protocadherin Fat 4 precursor (66%)</p><p>82. TVGVIVSREAMTGR Cadherin-like 23 (71%)</p><p>Interleukin-1 receptor associated kinase-2 (57%)</p><p>83. TYFCQQSYTTPLTFGGGTK Immunoglobulin kappa light chain variable region (100%)</p><p>Immunoglobulin light chain variable region (100%)</p><p>IgM monoclonal antibody light chain variable region (100%)</p><p>84. VCHSNLIESR B-cell lymphoma 6 protein isoform 2 (50%)</p><p>Olfactory receptor, family 52, subfamily E, member 8 (100%)</p><p>85. VHTGEKPYGCSECEKNLGK Zinc finger protein 614 (100%)</p><p>86. VSSHSSQATKDSGVGLK Immunoglobulin epsilon heavy chain variable region (41%)</p><p>87. YLAAAFPSACGK Activin A receptor, type IB, isoform CRA_c (50%)</p><p>88. APAHHPAAISTAK MHC class I antigen (38%)</p><p>89. APWWSSCRWR Leukocyte immunoglobulin-like receptor subfamily B member 5 (50%)</p><p>Carcinoembryonic antigen-related cell adhesion molecule 8 precursor (100%)</p><p>90. AEDTAVYYCAKJLTIR Immunoglobulin heavy chain variable region (100%)</p><p>91. AELGGLLSPR Immunoglobulin heavy chain subgroup VIII V-D-J region (70%)</p><p>9 92. AETLVFSTHAVISMR Immunoglobulin heavy chain variable region (66%)</p><p>93. DGSISILGSDDATTCHIVVLR Colony stimulating factor 1 receptor (61%)</p><p>Interleukin 1 recepter-like 2 (47%)</p><p>Immunoglobulin heavy chain variable region (33%)</p><p>94. GDRVTITWR Immunoglobulin kappa chain variable region (100%)</p><p>95. GGNSGGSSSICYVLLGFIGTSK T cell receptor beta variable 7 (68%)</p><p>Immunoglobulin heavy chain variable region (40%)</p><p>96. GLECIGYMYSSGSSFYNPSLKSR Immunoglobulin mu heavy chain variable region (100%)</p><p>97. GLEWVSAVSGSGTTTYYADSUK Immunoglobulin mu heavy chain variable region (100%)</p><p>98. GLSDSVRSCR Thymocyte antigen CD1d (60%)</p><p>Immunoglobulin heavy chain variable region (70%)</p><p>99. KAPQVYTIPPKE Anti-colorectal carcinoma heavy chain (100%)</p><p>Immunoglobulin heavy chain (66%)</p><p>100. KAPQVYTIPPKEQMAKD Anti-colorectal carcinoma heavy chain (100%)</p><p>Immunoglobulin heavy chain (88%)</p><p>101. KCELNCQAMGYR Immunoglobulin A heavy chain variable region (58%)</p><p>102. KNTQPIMDTDGSYFVYSKL Immunoglobulin heavy chain (100%)</p><p>103. KSSGTSYPDVLKC T cell receptor delta chain variable (61%)</p><p>104. KVTCVVVDISKD Hepatitis B virus receptor binding protein (75%)</p><p>10 Immunoglobulin heavy chain (75%)</p><p>Anti-colorectal carcinoma heavy chain (100%)</p><p>105. RLGEDNINVVEGNEQFISASKS T cell receptor variable alpha chain (50%)</p><p>106. LSSVTAADTNVYYCAR Immunoglobulin mu heavy chain variable region (100%)</p><p>107. RSVSELPIMHQDWLNGKE Hepatitis B virus receptor binding protein (100%)</p><p>Immunoglobulin heavy chain (100%)</p><p>108. RTLYLQMNSLR Immunoglobulin epsilon heavy chain variable region (90%)</p><p>Immunoglobulin heavy chain variable region (100%)</p><p>109. SLPGSPKDSSHLLSPLR Immunoglobulin heavy chain (VH4) variable region (41%)</p><p>110. SLVVAAVAPDNRNPAFTTMGWLFLK Immunoglobulin heavy chain variable region (52%)</p><p>B-cell receptor CD22 isoform 3 precursor (40%)</p><p>111. TAKGSTGMEILLSTLENTK Immunoglobulin A heavy chain variable region (94%)</p><p>112. TVFSDSQLSGLEK MHC class II transactivator (92%)</p><p>T-cell receptor alpha chain V region-human (fragment) (46%)</p><p>113. APTVVLMMTK Protein tyrosine kinase, receptor type, D (80%)</p><p>MHC class II antigen (80%)</p><p>Immunoglobulin heavy chain variable region (70%)</p><p>114. ATSRGCITIIGGGDTATCCAK Ephrin type-A receptor 5 (47%)</p><p>Immunoglobulin heavy chain variable region (57%)</p><p>11 Mucin-17 protein (33%)</p><p>115. GPLCGCCPGRSSQK Interleukin-4 receptor alpha chain (64%)</p><p>Immunoglobulin variable region (57%)</p><p>116. KAPSILSVLK Interleukin-12 receptor, beta 1, isoform CRA_b (90%)</p><p>117. KDVLTITLTPKV Truncated soluble vascular endothelial growth factor receptor</p><p>Anti-colorectal carcinoma heavy chain (100%)</p><p>Immunoglobulin lambda-light chain variable region (75%)</p><p>118.KGHQDSCPFELTACPNEGCTSQVPR TNF receptor-associated factor 6 (68%)</p><p>Immunoglobulin heavy chain variable region (32%)</p><p>119. KVCNYVSWIKQ CDC20-like protein, isoform CRA_g (81%)</p><p>Immunoglobulin heavy chain variable region (90%)</p><p>120. LSGSCRSTDSLHPCPPTALPR Microtubule-actin crosslinking factor 1, isoform CRA_i (80%)</p><p>Immunoglobulin light chain variable region (38%)</p><p>Mucin-3B, partial (80%)</p><p>121. MAYLQQTLAGPSGTR TNF receptor-associated factor 1 isoform b (40%)</p><p>Immunoglobulin kappa chain variable region (53%)</p><p>122. MSSNCTSTTAVAVAPLSASK TNF receptor superfamily , member 11a precursor variant (95%)</p><p>Mucin-19-like (100%)</p><p>Immunoglobulin heavy chain variable region (50%)</p><p>12 123. RVNSAAFPAPIEKT Mutant anaplastic lymphoma receptor tyrosine kinase (71%)</p><p>Anti-colorectal carcinoma heavy chain (100%)</p><p>Immunoglobulin heavy chain (64%)</p><p>124. TLSGSAALWAESEK Ephrin type-A receptor 10 isoform 3 (90%)</p><p>Immunoglobulin rearranged L-chain V-region (57%)</p><p>13</p>
Details
-
File Typepdf
-
Upload Time-
-
Content LanguagesEnglish
-
Upload UserAnonymous/Not logged-in
-
File Pages13 Page
-
File Size-